Search This Blog

Powered by Blogger.

Blog Archive

Labels

Showing posts with label Supernus Pharmaceuticals. Show all posts

Supernus Pharmaceuticals Hit by a Ransomware Attack

 

Last week, Supernus Pharmaceuticals, a biopharmaceutical company, claimed that it had been a target of a ransomware attack that led to a significant amount of information being compromised out of its system. As per the Rockville, Maryland-based firm, the extortion gang obtained data on certain systems, installed software to restrict file access, and then claimed to reveal the exfiltrated contents. 

Notwithstanding this, Supernus Pharmaceuticals argues that perhaps the occurrence had no significant effect on the business since its operations were not adversely affected. 

However, at this time, the Company seems to have no plans to pay any ransom money to any illegal ransomware organization. 

Supernus Pharmaceuticals also claims to have recovered the damaged files and also has undertaken efforts to boost the security of its network and data. Nevertheless, the organization believes that the crooks will most likely try to benefit from the unlawfully obtained information. 

The Hive ransomware group claimed responsibility for the attack, claiming that on November 14, it got into Supernus Pharmaceuticals' network and exfiltrated 1,268,906 files comprising 1.5 TB of data. 

“The Company continues to operate without interruption and does not currently anticipate paying any ransom amounts to any criminal ransomware group,” the company says. 

“To date, the Company has not paid any ransom and has been able to restore all of the information encrypted by the criminal ransomware group,” Supernus Pharmaceuticals further added. 

The hacker group claimed on its Tor network leak webpage that the stolen information would be uploaded online soon, stressing out that the corporation failed to notify the event in their most recent 8-K Form filed with the Securities and Exchange Commission (SEC). 

Meanwhile, Supernus Pharmaceuticals submitted an additional 8-K Form with the SEC on Friday 26th of November, this time specifically disclosing the ransomware attack. Considering Supernus Pharmaceuticals' assertion that it has no intention of paying a ransom, the Hive ransomware programmers say they have already been in contact with the company since the attack.